Permanent prostate brachytherapy: the significance of postimplant dosimetry.
Publication
, Journal Article
Lee, WR
Published in: Rev Urol
2004
Recent developments in imaging science and treatment-planning software allow for accurate postimplant dosimetric assessment in all patients after prostate brachytherapy. This article reviews the available data correlating cancer control and morbidity with dosimetric quantifiers obtained from postimplant dosimetric assessment after prostate brachytherapy. Continued collection of dosimetric data in patients treated with prostate brachytherapy will allow for further refinements in the technique, leading to continued high rates of cure with increasingly lower rates of morbidity.
Duke Scholars
Published In
Rev Urol
ISSN
1523-6161
Publication Date
2004
Volume
6 Suppl 4
Issue
Suppl 4
Start / End Page
S49 / S56
Location
United States
Citation
APA
Chicago
ICMJE
MLA
NLM
Lee, W. R. (2004). Permanent prostate brachytherapy: the significance of postimplant dosimetry. Rev Urol, 6 Suppl 4(Suppl 4), S49–S56.
Lee, W Robert. “Permanent prostate brachytherapy: the significance of postimplant dosimetry.” Rev Urol 6 Suppl 4, no. Suppl 4 (2004): S49–56.
Lee WR. Permanent prostate brachytherapy: the significance of postimplant dosimetry. Rev Urol. 2004;6 Suppl 4(Suppl 4):S49–56.
Lee, W. Robert. “Permanent prostate brachytherapy: the significance of postimplant dosimetry.” Rev Urol, vol. 6 Suppl 4, no. Suppl 4, 2004, pp. S49–56.
Lee WR. Permanent prostate brachytherapy: the significance of postimplant dosimetry. Rev Urol. 2004;6 Suppl 4(Suppl 4):S49–S56.
Published In
Rev Urol
ISSN
1523-6161
Publication Date
2004
Volume
6 Suppl 4
Issue
Suppl 4
Start / End Page
S49 / S56
Location
United States